Sensus Healthcare, Inc. (SRTS)

NASDAQ: SRTS · USD

$2.79

+0.00 (0.0%)· Recorded snapshot

Market cap	45.9M
Revenue (ttm)	17.5M
Net income (ttm)	-15.5M
EPS (ttm)	-$0.94
Shares out	16.5M
Volume	30,512
Beta	1.19

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 17.5M
Net income (ttm): -15.5M
EPS (ttm): -$0.94
Market cap: 45.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-34.8

P25 -113.8P50 -46.5P75 -0.9

ROIC-53.4

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All SRTS indicators

Market & fundamental data

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001494891
Company name	Sensus Healthcare, Inc.
Country	United States
Country code	US
CUSIP number	81728J109
Earnings date	2026-11-09
Earnings time	amc
Employees	60
Employees change	6
Employees growth	11.11%
Enterprise value	$31.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2010
Industry	Medical Devices
IPO date	2016-06-03
Is primary listing	Yes
Is SPAC	No
ISIN number	US81728J1097
Last 10-K release date	2026-03-04
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$45.9M
Market cap category	Nano-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$2.79
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	SRTS
U.S. state	Florida
Website	https://sensushealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (5Y)	20.54x
Earnings yield	-33.86%
EV/Sales	1.78x
FCF / EV yield	-22.42%
FCF yield	-15.18%
Forward EV/Sales	1.25x
Forward P/S	1.84x
Industry forward P/E	19.81x
Industry P/E	39.28x
P/B ratio	1.25x
P/S ratio	2.62x
Price / tangible book value	1.25x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-75.71%
EBITDA margin	-73.52%
Gross margin	36.39%
Operating margin	-75.71%
Pretax margin	-72.53%
Profit margin	-88.45%
Profit per employee	$-258,083
Revenue per employee	$291,783
ROA	-16.55%
ROA (5Y)	5.3%
ROCE	-35.89%
ROE	-34.83%
ROE (5Y)	16.33%
ROIC	-53.4%
ROIC (5Y)	19.85%
SBC / revenue	1.65%
Tax / revenue	15.92%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Gross profit growth	-67.5%
Gross profit growth (Q)	-73.51%
Gross profit growth 3Y	-29.86%
Gross profit growth 5Y	-6.32%
Net income growth years	0
Revenue growth	-53.39%
Revenue growth (Q)	-68.69%
Revenue growth (QoQ)	-32.53%
Revenue growth 10Y	3.38%
Revenue growth 3Y	-16.49%
Revenue growth 5Y	2.86%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-173,000
Depreciation and amortization	$383,000
EBIT	$-13.3M
EBITDA	$-12.9M
EPS	$-0.94
FCF per share	$-0.42
Financing cash flow	$-5,000
Free cash flow	$-7M
Free cash flow minus SBC	$-7.3M
Gross profit	$6.4M
Income taxes	$2.8M
Investing cash flow	$-173,000
Net cash flow	$-7M
Net income	$-15.5M
Operating cash flow minus SBC	$-7.1M
Operating income	$-13.3M
Revenue	$17.5M
Stock-based compensation	$289,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	8.87
Book value per share	$2.24
Debt / equity	0.01
Long-term assets	$3.6M
Long-term liabilities	$69,000
Net cash (debt)	$14.8M
Net cash / market cap	32.32%
Net cash growth	-31.18%
Net debt / equity	-0.4
Piotroski F-Score	2
Property, plant and equipment	$3.1M
Shareholders' equity	$36.9M
Tangible book value	$36.9M
Tangible book value per share	$2.24
Total assets	$41.3M
Total cash	$15.2M
Total debt	$343,000
Total liabilities	$4.4M
WACC	10.69%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.35
Current assets	$37.7M
Current liabilities	$4.3M
Current ratio	8.71
Inventory turnover	0.65
Net working capital	$18.4M
Quick ratio	3.9
Working capital	$33.4M
Working capital turnover	0.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.39%
Dividend yield	0%
Shareholder yield	-0.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-55.4%
10Y return CAGR	-7.76%
10Y total return	-55.4%
150-day SMA	$3.26
1D price change	0%
1M price change	-4.42%
1M total return	-4.42%
1W price change	-1.75%
1W total return	-1.75%
1Y price change	-13.8%
1Y return CAGR	-13.81%
1Y total return	-13.8%
20-day SMA	$2.88
200-day SMA	$3.56
3M price change	-6.95%
3M total return	-6.95%
3Y price change	28.31%
3Y return CAGR	8.66%
3Y total return	28.31%
50-day SMA	$3.06
50-day SMA vs 200-day SMA	50under200
52-week high	$5.49
52-week high date	2026-01-13
52-week low	$2.66
52-week low date	2026-06-16
5Y price change	-28.5%
5Y return CAGR	-6.49%
5Y total return	-28.5%
6M price change	-29.04%
6M total return	-29.04%
All-time high	$15.25
All-time high date	2022-08-12
All-time low	$1.76
All-time low date	2020-05-14
Average true range (ATR)	$0.14
Average volume	20.2K
Beta (1Y)	0.14
Beta (2Y)	0.31
Beta (5Y)	1.19
Change from 52-week high	-49.18%
Change from 52-week low	4.89%
Change from all-time high	-81.57%
Change from all-time low	59.66%
Change from open	1.82%
Day's gap	-1.79%
Dollar volume	$85,128
High price	$2.79
Low price	$2.74
Monthly RSI	42.04
Open price	$2.74
Position in 52-week range	100%
Previous close	$2.79
Price vs 150-day SMA	-13.67%
Price vs 20-day SMA	-2.26%
Price vs 200-day SMA	-21.07%
Price vs 50-day SMA	-8.05%
Relative volume	1.52
RSI	42.17
Sharpe ratio	0.03
Sharpe ratio (3Y)	0.42
Sharpe ratio (5Y)	0.3
Sortino ratio	0.14
Sortino ratio (3Y)	0.7
Sortino ratio (5Y)	0.49
Volume	30.5K
Weekly RSI	41.81
YTD price change	-29.4%
YTD total return	-29.4%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13.4M
Float percentage	81.33%
Shares change (QoQ)	-0%
Shares change (YoY)	0.39%
Shares held by insiders	18.67%
Shares held by institutions	25.18%
Shares outstanding	16.5M
Short % of float	1.7%
Short % of shares	1.38%
Short ratio	6.9 days

Deeper analysis on SRTS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SRTS report

Is a complete SRTS research report available?

No complete published report is available for Sensus Healthcare, Inc. (SRTS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Sensus Healthcare, Inc. (SRTS)

Price

Financial snapshot

Fair-value bridge

Latest news · SRTS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SRTS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SRTS

Frequently asked questions